Acquisitions - Additional Information (Detail) - USD ($) $ in Thousands						3 Months Ended	12 Months Ended
	Nov. 29, 2021	Sep. 20, 2021	Sep. 16, 2021	Jun. 22, 2021	Oct. 27, 2020	Dec. 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Business Acquisition [Line Items]
Payments to Acquire Businesses, Net of Cash Acquired							$ 149,893	$ 175,041	$ 182,154
Goodwill						$ 860,362	860,362	618,305	$ 468,413
Loss On Contingent Consideration Expense							5,865
Business combination contingent consideration							5,900
Selling, general and administrative
Business Acquisition [Line Items]
Transaction costs						4,700	4,700	4,000
BioFlex And NTM Acquisition
Business Acquisition [Line Items]
Value of common stock issued	$ 31,800
Net asset acquired	4,400
Fair value of acquired finite lived intangible assets	17,200
Goodwill						10,180	10,180
Intangible Asset Residual Value	$ 10,200
Transaction costs						300	$ 300
Business acquisition, voting interest acquired	100.00%
Business acquisition, Indemnification escrow	$ 3,000
Avitide Inc.
Business Acquisition [Line Items]
Cash consideration		$ 150,000	$ 75,000
Shares issued for business acquisition			271,096				271,096
Value of common stock issued			$ 83,000				$ 82,968
Net liabilities assumed			400
Business combination, consideration transferred							246,303
Fair value of acquired finite lived intangible assets			46,700
Goodwill						199,245	199,245
Intangible Asset Residual Value			199,200
Transaction costs						2,600	2,600
Loss On Contingent Consideration Expense						5,900
Business combination contingent consideration			88,400				88,373
Avitide Inc. | Capital Units
Business Acquisition [Line Items]
Cash consideration			150,000
Payments to Acquire Businesses, Net of Cash Acquired			149,400
Business combination, consideration transferred			275,000
Business combination contingent consideration			125,000
Business acquisition, Indemnification escrow			$ 800
Polymem S.A.
Business Acquisition [Line Items]
Cash consideration				$ 47,000
Net liabilities assumed						2,200	2,200
Fair value of acquired finite lived intangible assets						9,100	9,100
Goodwill						35,680	35,680
Intangible Asset Residual Value						35,700	35,700
Transaction costs						3,100	3,100
Business acquisition, Indemnification escrow							4,300
ARTeSYN Biosolutions
Business Acquisition [Line Items]
Cash consideration					$ 130,000		$ 130,700
Shares issued for business acquisition							372,990
Value of common stock issued					70,000		$ 69,422
Business combination, consideration transferred					200,000		203,993
Fair value of tangible assets acquired						8,000	8,000
Fair value of acquired finite lived intangible assets						67,400	67,400
Goodwill						128,598	128,598
Intangible Asset Residual Value						128,600	128,600
Business combination contingent consideration					$ 1,500		1,548
Working capital adjustment							100
Business Combination settlement of preexisting invoices							2,310
ARTeSYN Biosolutions | Goodwill [Member]
Business Acquisition [Line Items]
Intangible Asset Residual Value						128,600	128,600
Non Metallic Solutions
Business Acquisition [Line Items]
Business combination, consideration transferred							16,100
Fair value of tangible assets acquired						900	900
Fair value of acquired finite lived intangible assets						8,500	8,500
Goodwill						6,713	6,713
Intangible Asset Residual Value						6,700	6,700
Transaction costs						$ 500	500	$ 200
Business combinations cash deposited in escrow account							$ 1,300